Literature DB >> 9795580

Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population.

C R Peter1, E Schultz, K Moser, M Cox, R Freeman, M Ramirez-Zetina, M R Lomeli.   

Abstract

A study was conducted to determine the frequency of, and risk factors for, drug-resistant pulmonary tuberculosis (TB) among Baja California (BC) and San Diego County (SDC) residents. Another purpose was to document the amount of contact between pulmonary TB patients and residents of the opposite side of the the border. During the period from February 1995 to May 1996, pulmonary TB patients from BC (n = 427) and SDC (n = 331) were evaluated with cultures, drug susceptibility tests, and questionnaires. Drug resistance was found in 41% of the BC Mycobacterium tuberculosis complex (MTB) isolates and 20% of the SDC isolates. Resistance to both isoniazid (INH) and rifampin (RIF) varied from 1% of isolates from SDC patients to 17% of isolates from BC patients. Patients with a history of previous treatment had increased odds of drug-resistant disease. Older BC patients were more likely to have INH- or RIF-resistant TB. Although 42% of Tijuana TB patients reported recent contact with residents from SDC, travel to Mexico and contact with residents from Mexico were not significant risk factors for drug-resistant TB among SDC residents. However, the demonstrated contact between TB patients and residents on opposite sides of the border indicates the importance of coordinating efforts internationally to control TB.

Entities:  

Mesh:

Year:  1998        PMID: 9795580      PMCID: PMC1305288     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  10 in total

1.  Trends in drug-resistant tuberculosis in the United States, 1993-1996.

Authors:  M Moore; I M Onorato; E McCray; K G Castro
Journal:  JAMA       Date:  1997-09-10       Impact factor: 56.272

2.  Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain)

Authors:  M Arévalo; J Solera; D Cebrian; J Bartolomé; P Robles
Journal:  Eur Respir J       Date:  1996-02       Impact factor: 16.671

3.  Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.

Authors:  M T Mendoza; A J Gonzaga; C Roa; M A Velmonte; M Jorge; J C Montoya; T Tan Torres; M Ong; M Y Barez; C F Ang
Journal:  Int J Tuberc Lung Dis       Date:  1997-02       Impact factor: 2.373

4.  Drug-resistant tuberculosis: factors associated with rise in resistance in an HIV-infected urban population.

Authors:  N Salomon; D C Perlman; V A DePalo; A Kolokathis; I Wilets
Journal:  Mt Sinai J Med       Date:  1994-09

Review 5.  The epidemiology of multidrug-resistant tuberculosis in the United States.

Authors:  J H Kent
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

6.  [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors].

Authors:  J Sifuentes-Osornio; L A Ponce-de-León; F E Camacho-Mezquita; J M Bobadilla-del-Valle; M L Infante-Suárez; N Ramírez-Fernández; L Hernández-Gómez; A M Nelson
Journal:  Rev Invest Clin       Date:  1995 Jul-Aug       Impact factor: 1.451

7.  Drug-resistant tuberculosis in Puerto Rico, 1987-1990.

Authors:  G Grandes; J Lopez-de-Munain; T Diaz; J V Rullan
Journal:  Am Rev Respir Dis       Date:  1993-07

8.  The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections: a community-based study.

Authors:  L W Riley; E Arathoon; V D Loverde
Journal:  Am Rev Respir Dis       Date:  1989-05

9.  [Risk factors for antitubercular drug resistance in Chiapas, Mexico].

Authors:  G C Alvarez-Gordillo; D Halperin-Frisch; L Blancarte-Melendres; J L Vázquez-Castellanos
Journal:  Salud Publica Mex       Date:  1995 Sep-Oct

Review 10.  Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen.

Authors:  W M Dankner; N J Waecker; M A Essey; K Moser; M Thompson; C E Davis
Journal:  Medicine (Baltimore)       Date:  1993-01       Impact factor: 1.889

  10 in total
  6 in total

1.  Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas border.

Authors:  J P Taylor; L Suarez
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

2.  Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women.

Authors:  E Joo; A Carmack; E Garcia-Buñuel; C J Kelly
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

3.  First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.

Authors:  Rocio Lopez-Alvarez; Claudia Badillo-Lopez; Jorge F Cerna-Cortes; Ivan Castillo-Ramirez; Sandra Rivera-Gutierrez; Addy C Helguera-Repetto; Diana Aguilar; Rogelio Hernandez-Pando; Sofia Samper; Jorge A Gonzalez-y-Merchand
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

4.  Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California.

Authors:  Ietza Bojorquez; Richard F W Barnes; Jennifer Flood; Hugo López-Gatell; Richard S Garfein; Claudia E Bäcker; Celia Alpuche; Joseph M Vinetz; Antonino Catanzaro; Midori Kato-Maeda; Timothy C Rodwell
Journal:  Am J Public Health       Date:  2013-05-16       Impact factor: 9.308

5.  Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.

Authors:  Robert Deiss; Richard S Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C Brouwer; Kathleen S Moser; Maria Luisa Zuniga; Timothy C Rodwell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

6.  Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico.

Authors:  Mercedes Macías Parra; Jesús Kumate Rodríguez; José Luís Arredondo García; Yolanda López-Vidal; Mauricio Castañón-Arreola; Susana Balandrano; Nalin Rastogi; Pedro Gutiérrez Castrellón
Journal:  Tuberc Res Treat       Date:  2011-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.